| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $21.75B | $22.49B | $18.95B |
| YoY Revenue Growth % | -3.3% | +18.7% | — |
| Gross Profit | — | $5.98B | — |
| Gross Margin % | — | 26.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $2.17B | $2.65B | $2.16B |
| Operating Margin % | 10.0% | 11.8% | 11.4% |
| Net Income (GAAP) | $1.48B | $5.60B | $1.35B |
| EBITDA (Normalized) | $2.95B | $3.46B | $2.84B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $2.51B | $563.0M | $2.61B |
| Capital Expenditures (CapEx) | $978.6M | $1.01B | $852.8M |
| Free Cash Flow (FCF) | $1.53B | -$448.9M | $1.75B |
| FCF Margin % | 7.1% | -2.0% | 9.3% |
| Return on Invested Capital (ROIC %) | 7.2% | 9.7% | 11.2% |
| Cash & Short-Term Equivalents | $1.55B | $3.97B | — |
| Total Debt (Short + Long Term) | $11.37B | $11.03B | $5.89B |
| Total Stockholders' Equity | $14.13B | $14.39B | $12.09B |